Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

181 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Spotlight on advances in VTE management: CALLISTO and EINSTEIN CHOICE.
Bach M, Bauersachs R. Bach M, et al. Among authors: bauersachs r. Thromb Haemost. 2016 Sep 28;116(Suppl. 2):S24-S32. doi: 10.1160/TH16-06-0486. Epub 2016 Sep 14. Thromb Haemost. 2016. PMID: 27623682
A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery.
Lindhoff-Last E, Eichler P, Stein M, Plagemann J, Gerdsen F, Wagner R, Ehrly AM, Bauersachs R. Lindhoff-Last E, et al. Among authors: bauersachs r. Thromb Res. 2000 Mar 15;97(6):387-93. doi: 10.1016/s0049-3848(99)00198-x. Thromb Res. 2000. PMID: 10704647
Hirudin determination in plasma can be strongly influenced by the prothrombin level.
Lindhoff-Last E, Piechottka GP, Rabe F, Bauersachs R. Lindhoff-Last E, et al. Among authors: bauersachs r. Thromb Res. 2000 Oct 1;100(1):55-60. doi: 10.1016/s0049-3848(00)00303-0. Thromb Res. 2000. PMID: 11053617
R-hirudin (0.0-2.0 microg/mL) was added to plasma samples with decreasing prothrombin concentrations (100-0%). Using the ECT, false high r-hirudin levels were observed even in r-hirudin-free plasma, when prothrombin levels were below 50%. This effect was more
R-hirudin (0.0-2.0 microg/mL) was added to plasma samples with decreasing prothrombin concentrations (100-0%). Using the ECT, false h
[Therapy and secondary prevention of venous thromboembolism with vitamin K antagonists].
Bauersachs RM. Bauersachs RM. Internist (Berl). 2003 Dec;44(12):1491-9. doi: 10.1007/s00108-003-1081-7. Internist (Berl). 2003. PMID: 14689191 Review. German.
[Modern anticoagulation. Problems of the proven, hope for the new].
Bauersachs R, Breddin HK. Bauersachs R, et al. Internist (Berl). 2004 Jun;45(6):717-26. doi: 10.1007/s00108-004-1161-3. Internist (Berl). 2004. PMID: 15107981 Review. German.
[Home treatment for deep vein thrombosis: pros and cons].
Bauersachs R, Haas S, Schellong S. Bauersachs R, et al. Hamostaseologie. 2004 Aug;24(3):167-72. doi: 10.1267/hamo04030167. Hamostaseologie. 2004. PMID: 15314701 Review. German.
[Treatment of deep vein thrombosis. When to use which substance?].
Bauersachs RM. Bauersachs RM. Internist (Berl). 2004 Dec;45(12):1345-55. doi: 10.1007/s00108-004-1302-8. Internist (Berl). 2004. PMID: 15517122 Review. German.
Fondaparinux: an update on new study results.
Bauersachs RM. Bauersachs RM. Eur J Clin Invest. 2005 Mar;35 Suppl 1:27-32. doi: 10.1111/j.0960-135X.2005.01454.x. Eur J Clin Invest. 2005. PMID: 15701145 Review.
[Treatment options in deep vein thrombosis].
Bauersachs RM. Bauersachs RM. MMW Fortschr Med. 2005 Nov 24;147(47):40-2, 44-6. MMW Fortschr Med. 2005. PMID: 16370194 German.
Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, Harenberg J, Herchenhan E, Keller F, Kemkes-Matthes B, Schinzel H, Spannagl M, Thaler CJ; EThIG Investigators. Bauersachs RM, et al. Thromb Haemost. 2007 Dec;98(6):1237-45. doi: 10.1160/th07-05-0329. Thromb Haemost. 2007. PMID: 18064320 Clinical Trial.
181 results
Jump to page
Feedback